Modern smart collars have evolved from simple GPS trackers to sophisticated biometric instruments capable of early disease ...
Recently, a manufacturer of pouch-style batteries for EVs approached Spectro Physics to see if the company could help test ...
ProLogium Technology, a leader in solid-state battery R&D and mass production, today announced that it will co-exhibit with FEV Group, a globally leading innovation driver for mobility solutions and ...
Benzinga on MSN
Top 5 Stocks To Watch Today | December 30th
US stock futures are trading mixed this Tuesday morning as investors focus on sharp moves driven by private placements, take-private deals, and biotech updates. Here are the stocks investors are ...
Xellar Biosystems ("Xellar"), a globally leading innovator in next-generation artificial intelligence- and computer vision?assisted, organ-on-a-chip?based drug discovery and development platforms, ...
Boehringer Ingelheim has announced GenoSource LLC of Blairstown, Iowa, as the 2025 Dairy First Award recipient, an annual honor recognizing a dairy operation’s commitment to milk quality and overall ...
New scientific methods could one day render animal studies—the standard in research laboratories for more than 100 ...
One of the biggest quests in biology is understanding how every cell in an animal's body carries an identical genome yet still gives rise to a kaleidoscope of different cell types and tissues. A ...
For the last two years, the cultivated meat industry has been experiencing growing pains. Many startups have shrunk, shut ...
According to a regulatory filing, the addition of the latest unit brings Emmvee’s total solar module manufacturing capacity to 10.3GW. Image: Emmvee. PV manufacturer Emmvee Photovoltaic Power, through ...
23hon MSN
T cells gain superior memory through new reprogramming method, boosting cancer-fighting abilities
Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, ...
Intestinal Stem Cells (ISCs) derived from a patient's own cells have garnered significant attention as a new alternative for treating intractable intestinal diseases due to their low risk of rejection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results